You are here

Victoza

Novo Nordisk shares hit by concerns over rival diabetes drugs

Reuters

Mon, 06/17/13 - 09:17 am

Diabetes Drugs Under Scrutiny As FDA Considers Another Study

Pharmalot

Wed, 06/12/13 - 12:40 pm

Bristol-Myers Squibb

Boehringer Ingelheim

Is Novo A Threat To Arena, Vivus, And Orexigen?

Seeking Alpha

Thu, 05/30/13 - 09:02 am

Arena Pharmaceuticals

Will Obesity Drugs Gain Soon?

Motley Fool

Wed, 05/15/13 - 09:50 am

Arena Pharmaceuticals

Victoza weight-loss nod could rescue Novo from Tresiba delay, CEO says

Fierce Pharma

Thu, 05/9/13 - 09:48 am

Novo Nordisk Says Trial Shows Victoza Helps Patients Lose Weight

Bloomberg

Mon, 03/18/13 - 11:22 am

Diabetes Drugs Are Being Evaluated for Pancreatic Risk

Bloomberg

Thu, 03/14/13 - 11:15 am

pancreatic cancer

Bristol-Myers Squibb

Glaxo Doubts GLP-1s Would Be Cleared as Drugs for Obesity

Bloomberg

Tue, 12/4/12 - 11:55 am

Novo Nordisk says new data show Victoza advantage

Reuters

Tue, 11/27/12 - 10:36 am

Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth

Seeking Alpha

Tue, 11/13/12 - 12:11 pm

Novo raises targets on Victoza, insulin demand

Yahoo/Reuters

Thu, 08/9/12 - 11:35 am

Sanofi, Novo Nordisk, Amylin all tout diabetes treatments at ADA

Fierce Pharma

Mon, 06/11/12 - 01:17 pm

Novo's Victoza Leads To Greater Weight Loss Than Byetta

Bloomberg

Mon, 06/11/12 - 10:47 am

Novo Nordisk rejects diabetes drug Victoza complaint

Reuters

Fri, 04/20/12 - 11:02 am

Novo Nordisk says diabetes drug Victoza superior to Merck rival

Reuters

Sat, 04/7/12 - 11:56 am

Novo Nordisk to move forward with once-weekly diabetes shot, Bloomberg says

Yahoo/Fly on the Wall

Mon, 04/2/12 - 12:02 pm

FDA nod fuels Bydureon vs. Victoza bout

Fierce Pharma

Mon, 01/30/12 - 04:00 pm

Full of News, but Worth a 15% Gain? (Amylin)

Motley Fool

Sat, 10/22/11 - 12:27 pm

Novo Nordisk's Data at EASD

Yahoo/Zacks.com

Thu, 09/15/11 - 11:51 am

Lilly, Amylin, Merck Diabetes Drug Risks Highlighted

Minyanville

Tue, 09/13/11 - 02:18 pm

Pages